1. Novel Intrafraction Motion Tracking During Postoperative Spine Stereotactic Irradiation for a Patient With Carbon Fiber Fixation Hardware.
- Author
-
Lee-Poprocki H, Ritter AR, Upadhyay R, Perlow HK, Ayan AS, Cetnar AJ, Degnan M, Scharschmidt TJ, Mendel E, Blakaj DM, Thomas EM, Chakravarthy VB, Elder JB, and Palmer JD
- Subjects
- Female, Humans, Middle Aged, Carbon Fiber, Tantalum therapeutic use, Polymers, Polyethylene Glycols, Ketones, Radiosurgery
- Abstract
Carbon-fiber reinforced (CFR) polyetheretherketone hardware is an alternative to traditional metal hardware used for spinal fixation surgeries before postoperative radiation therapy for patients with spinal metastases. CFR hardware's radiolucency decreases metal artifact, improving visualization and accuracy of treatment planning. We present the first clinical use and proof of principle of CFR spinal hardware with tantalum markers used for successful tracking of intrafraction motion (IM) using Varian TrueBeam IMR (Intrafraction Motion Review) software module during postoperative spine stereotactic radiation. A 63-year-old woman with history of endometrial cancer presented with acute back pain. Imaging demonstrated pathologic T12 vertebral fracture with cord compression. She underwent T12 vertebrectomy with circumferential decompression and posterior instrumented T10-L2 fusion at our facility using CFR-polyetheretherketone hardware with tantalum screw markers followed by postoperative stereotactic body radiation therapy to 3000 cGy in 5 fractions delivered to T11-T12. Tantalum screw markers were used for IMR tracking. During irradiation, 260 kV images were acquired, and IMR software was able to identify and track markers. During the entire treatment, the IM motions were less than 3 mm. This is the first presented case of CFR spinal hardware with tantalum markers used for successful IMR tracking of IM during daily spine stereotactic treatment. Future work will be needed to improve workflow and create a spine-specific IMR protocol., Competing Interests: Disclosures JDP reports research and speaking fees from Icotec, outside submitted work: Varian speeking fees, Novocure advisory board, Kroger trial funding, NIH R01CA269948, NIH R702 award, Biocept clinical trial funding, genentech clinical trial funding, (Copyright © 2023 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF